Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for HilleVax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-31 2:00 pm Purchase |
2024-05-29 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 10,639,562 21.400% |
833,090 (+8.50%) |
Filing |
| 2023-09-27 10:26 am Purchase |
2023-09-25 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% |
25,000 (+0.26%) |
Filing |
| 2023-05-05 4:12 pm Purchase |
2023-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% |
144,240 (+1.50%) |
Filing |
| 2022-09-08 1:19 pm Purchase |
2022-09-06 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,637,232 28.800% |
513,660 (+5.63%) |
Filing |
| 2022-05-06 4:15 pm Purchase |
2022-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,123,572 27.300% |
9,123,572 (New Position) |
Filing |